We are live on ! Find out more
OC

Oarsman Capital Portfolio holdings

AUM $806M
1-Year Est. Return 19.96%
This Fund
S&P 500
This Quarter Est. Return
+17.56%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$202M
AUM Growth
+$94.1M
Cap. Flow
+$74.6M
Cap. Flow %
36.85%
Top 10 Hldgs %
30.03%
Holding
178
New
58
Increased
83
Reduced
16
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 15.83%
2 Healthcare 13.32%
3 Financials 7.65%
4 Communication Services 6.92%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYG icon
1
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
$9.56M 4.72%
212,729
+42,753
+25% +$1.78M
MSFT icon
2
Microsoft
MSFT
$2.84T
$8.61M 4.25%
42,285
+25,958
+159% +$4.71M
AAPL icon
3
Apple
AAPL
$4.89T
$7.14M 3.53%
78,288
+26,640
+52% +$2.06M
GLD icon
4
SPDR Gold Trust
GLD
$131B
$7.12M 3.52%
42,551
+20,887
+96% +$3.37M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$3.9T
$6.47M 3.2%
91,580
+44,580
+95% +$3.01M
SPYV icon
6
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$5.64M 2.79%
194,523
+56,558
+41% +$1.61M
JNJ icon
7
Johnson & Johnson
JNJ
$635B
$4.4M 2.18%
31,301
+11,058
+55% +$1.61M
FISV
8
Fiserv Inc
FISV
$27.2B
$4.07M 2.01%
41,659
+15,607
+60% +$1.57M
ABBV icon
9
AbbVie
ABBV
$458B
$3.94M 1.95%
40,131
+19,555
+95% +$1.72M
SPAB icon
10
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
$3.83M 1.89%
124,247
+25,870
+26% +$790K
CVS icon
11
CVS Health
CVS
$137B
$3.64M 1.8%
56,038
+13,097
+30% +$825K
SH icon
12
ProShares Short S&P500
SH
$887M
$3.62M 1.79%
40,477
-402
-1% -$38.6K
VZ icon
13
Verizon
VZ
$194B
$3.51M 1.74%
63,731
+16,874
+36% +$949K
KMB icon
14
Kimberly-Clark
KMB
$36.4B
$3.34M 1.65%
23,609
+9,823
+71% +$1.36M
INTC icon
15
Intel
INTC
$466B
$3.31M 1.64%
55,398
+21,956
+66% +$1.31M
SPSM icon
16
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$3.31M 1.64%
124,606
+49,903
+67% +$1.23M
AMZN icon
17
Amazon
AMZN
$2.5T
$3.25M 1.61%
23,560
+6,980
+42% +$843K
PEP icon
18
PepsiCo
PEP
$186B
$3.21M 1.59%
24,287
+9,329
+62% +$1.23M
JPM icon
19
JPMorgan Chase
JPM
$939B
$2.67M 1.32%
28,372
+11,331
+66% +$1.08M
MTG icon
20
MGIC Investment
MTG
$6.27B
$2.66M 1.32%
324,884
+126,999
+64% +$950K
SPDW icon
21
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.7B
$2.62M 1.3%
95,015
-449
-0.5% -$11.8K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.36M 1.16%
13,202
+3,922
+42% +$716K
NVS icon
23
Novartis
NVS
$295B
$2.34M 1.15%
26,749
+15,234
+132% +$1.31M
IJS icon
24
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$2.28M 1.13%
+37,920
New +$2.13M
UNH icon
25
UnitedHealth
UNH
$382B
$2.28M 1.13%
7,719
+1,084
+16% +$311K

Similar funds

Oarsman Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Oarsman Capital held 178 positions worth $202M, up 87% from $108M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Oarsman Capital deployed $74.6M of net new capital in Q2 2020, opening 58 new positions and adding to 83 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 37,920 shares worth $2.28M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR Portfolio Emerging Markets ETF, an estimated $1.23M trimmed.

  • Oarsman Capital's largest Q2 2020 buy was iShares S&P Small-Cap 600 Value ETF: 37,920 shares worth $2.28M.
  • Oarsman Capital added most to Microsoft in Q2 2020, an estimated $4.71M increase.
  • Oarsman Capital's biggest Q2 2020 reduction was State Street SPDR Portfolio Emerging Markets ETF, cutting an estimated $1.23M.
  • Oarsman Capital fully exited Western Digital in Q2 2020, selling an estimated $631K.
  • Oarsman Capital's ten largest holdings make up 30% of its $202M portfolio in Q2 2020.
  • Oarsman Capital opened 58 new positions and closed 4 in Q2 2020.
  • Oarsman Capital's portfolio value rose 87% quarter-over-quarter to $202M.

Based on Oarsman Capital's 13F filing for Q2 2020, filed 13 Aug 2020.